Vanguard Group’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.7M Buy
405,354
+124,271
+44% +$522K ﹤0.01% 3587
2025
Q1
$1.34M Buy
281,083
+2,861
+1% +$13.6K ﹤0.01% 3622
2024
Q4
$1.06M Buy
278,222
+14,258
+5% +$54.3K ﹤0.01% 3746
2024
Q3
$2.37M Buy
263,964
+4,252
+2% +$38.1K ﹤0.01% 3502
2024
Q2
$2.53M Sell
259,712
-1,119
-0.4% -$10.9K ﹤0.01% 3485
2024
Q1
$3.54M Buy
260,831
+102,338
+65% +$1.39M ﹤0.01% 3421
2023
Q4
$1.74M Buy
158,493
+2,057
+1% +$22.5K ﹤0.01% 3652
2023
Q3
$1.6M Sell
156,436
-810
-0.5% -$8.29K ﹤0.01% 3662
2023
Q2
$2.48M Sell
157,246
-748
-0.5% -$11.8K ﹤0.01% 3587
2023
Q1
$3.57M Buy
157,994
+12,215
+8% +$276K ﹤0.01% 3462
2022
Q4
$5.2M Buy
145,779
+15,941
+12% +$569K ﹤0.01% 3288
2022
Q3
$5.06M Buy
129,838
+14,168
+12% +$552K ﹤0.01% 3321
2022
Q2
$5.55M Sell
115,670
-4,379
-4% -$210K ﹤0.01% 3327
2022
Q1
$11.1M Buy
120,049
+11,906
+11% +$1.1M ﹤0.01% 3094
2021
Q4
$24M Buy
108,143
+5,069
+5% +$1.13M ﹤0.01% 2741
2021
Q3
$35.7M Buy
103,074
+10,005
+11% +$3.46M ﹤0.01% 2545
2021
Q2
$35M Buy
93,069
+15,968
+21% +$6M ﹤0.01% 2557
2021
Q1
$23.9M Sell
77,101
-4,182
-5% -$1.3M ﹤0.01% 2689
2020
Q4
$20.3M Buy
81,283
+11,100
+16% +$2.78M ﹤0.01% 2623
2020
Q3
$13M Buy
70,183
+15,342
+28% +$2.84M ﹤0.01% 2659
2020
Q2
$13.7M Buy
54,841
+8,386
+18% +$2.1M ﹤0.01% 2612
2020
Q1
$8.4M Buy
46,455
+12,592
+37% +$2.28M ﹤0.01% 2698
2019
Q4
$14.1M Buy
33,863
+17,177
+103% +$7.16M ﹤0.01% 2693
2019
Q3
$4.2M Buy
16,686
+2,452
+17% +$617K ﹤0.01% 3199
2019
Q2
$5.66M Buy
14,234
+11,734
+469% +$4.66M ﹤0.01% 3125
2019
Q1
$1.35M Buy
+2,500
New +$1.35M ﹤0.01% 3549